Abstract
Peter Mwaba, Innocent Mwaba, Minyoi Mubita Maimbolwa, Chitalu Chanda, Muhammad Mputu, C.M. Lumbwe, Kevin M. Zimba, Nancy Kasese Chanda, Rhehab B Chimzizi, Angel Mubanga, Monde Muyoyeta, Mary Kagujje
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021
10.1186/s40249-024-01227-y · 2024
Unresolved referenced work
Kept as external metadata until matched
Tuberculosis preventive treatment in high TB-burden settings: A state-of-the-art review
10.1007/s40265-024-02131-3 · 2025
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies
10.1016/s2213-2600(24)00083-3 · 2024
A controlled trial of community-wide isoniazid prophylaxis in Alaska
1967
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Systematic review of the exploration, preparation, implementation, sustainment (EPIS) framework
10.1186/s13012-018-0842-6 · 2019
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
10.1183/13993003.00655-2019 · 2019
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Reasons for poor uptake of TB preventive therapy in South Africa
10.5588/pha.22.0030 · 2022
Exploring providers’ perspectives of a community based TB approach in Southern Ethiopia: Implication for community based approaches
10.1186/s12913-015-1149-9 · 2015
The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis
10.1016/s1473-3099(16)30216-x · 2016
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: A cluster-randomised trial
10.1016/s2214-109x(23)00430-8 · 2023
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
10.15585/mmwr.rr6901a1 · 2020
The global burden of tuberculosis mortality in children: a mathematical modelling study
2017
Unresolved referenced work
Kept as external metadata until matched
The Prevalence and clinical manifestations of post-tuberculosis lung disease in immunocompetent HIV-negative individuals: A scoping review
2025
Post-tuberculosis lung disease: Towards prevention, diagnosis, and care
10.1016/s2213-2600(24)00429-6 · 2025
Patient outcomes associated with post-tuberculosis lung damage in Malawi: A prospective cohort study
10.1136/thoraxjnl-2019-213808 · 2020
Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru
10.1186/s12889-020-10098-5 · 2021
Programmatic management of tuberculosis preventive therapy: past, present, future
10.1016/j.ijid.2023.02.016 · 2023
Perceived stigma related to TB preventive therapy
10.5588/ijtld.22.0570 · 2023
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: A qualitative study of adolescents, caretakers and health workers
10.1186/s12981-024-00643-2 · 2024
The impacts of donor transitions on health systems in middle-income countries: A scoping review
10.1093/heapol/czac063 · 2022
The impact of loss of PEPFAR support on HIV services at health facilities in low-burden districts in Uganda
10.1186/s12913-021-06316-4 · 2021
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
10.5588/ijtldopen.23.0283 · 2024
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
10.5588/ijtldopen.23.0283 · 2024
Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: A systematic review
10.1186/s12879-025-10832-7 · 2025
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: An individual patient data network meta-analysis
10.1016/s2213-2600(23)00096-6 · 2023
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: A systematic review with network meta-analyses
10.1186/s12879-017-2377-x · 2017
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
10.1016/s2213-2600(23)00096-6 · 2023
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
10.1371/journal.pgph.0003347 · 2024
Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda [Internet]
2022
More is needed to end TB: Commentary on the United Nations High-Level Meeting on TB
10.5588/ijtldopen.23.0576 · doi-reference
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
10.1371/journal.pgph.0003347 · doi-reference
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: A systematic review with network meta-analyses
10.1186/s12879-017-2377-x · doi-reference
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
10.1016/s2213-2600(23)00096-6 · doi-reference
Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: A systematic review
10.1186/s12879-025-10832-7 · doi-reference
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
10.5588/ijtldopen.23.0283 · doi-reference
The impact of loss of PEPFAR support on HIV services at health facilities in low-burden districts in Uganda
10.1186/s12913-021-06316-4 · doi-reference
The impacts of donor transitions on health systems in middle-income countries: A scoping review
10.1093/heapol/czac063 · doi-reference
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: A qualitative study of adolescents, caretakers and health workers
10.1186/s12981-024-00643-2 · doi-reference
Perceived stigma related to TB preventive therapy
10.5588/ijtld.22.0570 · doi-reference
Programmatic management of tuberculosis preventive therapy: past, present, future
10.1016/j.ijid.2023.02.016 · doi-reference
Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru
10.1186/s12889-020-10098-5 · doi-reference
Patient outcomes associated with post-tuberculosis lung damage in Malawi: A prospective cohort study
10.1136/thoraxjnl-2019-213808 · doi-reference
Post-tuberculosis lung disease: Towards prevention, diagnosis, and care
10.1016/s2213-2600(24)00429-6 · doi-reference
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
10.15585/mmwr.rr6901a1 · doi-reference
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: A cluster-randomised trial
10.1016/s2214-109x(23)00430-8 · doi-reference
The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis
10.1016/s1473-3099(16)30216-x · doi-reference
Exploring providers’ perspectives of a community based TB approach in Southern Ethiopia: Implication for community based approaches
10.1186/s12913-015-1149-9 · doi-reference
Reasons for poor uptake of TB preventive therapy in South Africa
10.5588/pha.22.0030 · doi-reference
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
10.1183/13993003.00655-2019 · doi-reference
Systematic review of the exploration, preparation, implementation, sustainment (EPIS) framework
10.1186/s13012-018-0842-6 · doi-reference
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies
10.1016/s2213-2600(24)00083-3 · doi-reference
Tuberculosis preventive treatment in high TB-burden settings: A state-of-the-art review
10.1007/s40265-024-02131-3 · doi-reference
Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021
10.1186/s40249-024-01227-y · doi-reference